Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information... Show more
FLGT is expected to report earnings to rise 21.89% to -43 cents per share on July 31
Q2'26
Est.
$-0.44
Q1'26
Missed
by $0.25
Q4'25
Beat
by $0.22
Q3'25
Beat
by $0.36
Q2'25
Beat
by $0.25
The last earnings report on May 01 showed earnings per share of -36 cents, missing the estimate of -10 cents. With 505.91K shares outstanding, the current market capitalization sits at 566.88M.